Published in Thromb Haemost on March 01, 2001
Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood (2005) 1.64
The presence of gamma' chain impairs fibrin polymerization. Thromb Res (2009) 1.06
The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice. J Thromb Haemost (2014) 0.88
Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site. Thromb Haemost (2008) 0.79
Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain. Biochemistry (2012) 0.76
Primed to Understand Fibrinogen in Cardiovascular Disease. Arterioscler Thromb Vasc Biol (2016) 0.75
Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing. Adv Wound Care (New Rochelle) (2015) 0.75
Role of tyrosine-sulfated proteins in retinal structure and function. Exp Eye Res (2015) 0.75
Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arterioscler Thromb Vasc Biol (2017) 0.75
The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem (1970) 4.49
Structure and variation of human alpha 1-antitrypsin. Nature (1982) 4.13
Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93
Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J Clin Invest (1977) 2.96
The structure and biologic activities of plasma fibronectin. Blood (1980) 2.94
The cold-insoluble globulin of human plasma: studies of its essential structural features. Biochim Biophys Acta (1975) 2.51
The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci (2001) 2.48
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med (1983) 2.36
Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy. J Mol Biol (1981) 2.01
Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol (2001) 1.76
Heterogeneity of the cold-insoluble globulin of human plasma (CIg), a circulating cell surface protein. Biochim Biophys Acta (1977) 1.54
Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes. J Clin Invest (1973) 1.54
A circulating variant of human proalbumin. Nature (1978) 1.52
Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost (2001) 1.48
Apolipoprotein E variation in patients with hyperlipidaemia: DNA and protein phenotyping. N Z Med J (1989) 1.39
Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease. Arthritis Rheum (1981) 1.38
Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. J Biol Chem (1972) 1.37
Production of fibronectin by human epithelial cells in culture. Cancer Res (1979) 1.34
The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry (1966) 1.31
Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest (1979) 1.22
Control of a cell surface major glycoprotein by epidermal growth factor. Science (1977) 1.21
Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res (1997) 1.19
Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility. Biochemistry (1967) 1.17
Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry (1996) 1.16
An improved method for purification of the cold-insoluble globulin of human plasma (CLg). Anal Biochem (1977) 1.16
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood (1987) 1.16
The molecular abnormality of albumin Parklands: 365 Asp----His. Biochim Biophys Acta (1985) 1.16
Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells. Lab Invest (1979) 1.15
Yeast KEX2 protease has the properties of a human proalbumin converting enzyme. Science (1987) 1.13
Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem (1996) 1.13
Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci U S A (1989) 1.10
Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma. Blood (1978) 1.10
Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). Proc Natl Acad Sci U S A (1980) 1.08
The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. J Struct Biol (1995) 1.06
Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular junction. Blood (1993) 1.06
Chronic intravascular coagulation syndrome. N Engl J Med (1968) 1.06
Human platelet fibrinogen: purification and hemostatic properties. Blood (1985) 1.05
Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem J (1997) 1.05
Human fibrinogen heterogeneities. 3. Identification of chain variants. J Biol Chem (1972) 1.04
Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology. FEBS Lett (1981) 1.02
Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives. J Biol Chem (1974) 1.01
Latent antithrombin and its detection, formation and turnover in the circulation. J Thromb Haemost (2004) 1.00
Functional abnormality of proalbumin Christchurch. Biochim Biophys Acta (1980) 1.00
The cold-insoluble globulin of plasma and its relationship to factor VIII. J Lab Clin Med (1974) 1.00
The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. J Biol Chem (1973) 0.99
Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol (1997) 0.99
Characterization of the gamma chain platelet binding site on fibrinogen fragment D. Blood (1992) 0.99
Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen). J Biol Chem (2000) 0.99
Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost (2002) 0.99
Purification and characterization of the candidate prohormone-processing enzyme SPC3 produced in a mouse L cell line. J Biol Chem (1993) 0.98
Human fibrinogen heterogeneities: distribution and charge characteristics of chains of A alpha origin. J Lab Clin Med (1978) 0.97
The molecular mechanisms of congenital hypofibrinogenaemia. Cell Mol Life Sci (2004) 0.97
The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys). J Clin Invest (1995) 0.97
Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis. J Biol Chem (1994) 0.96
Effect of hepatocyte-stimulating factor and glucocorticoids on plasma fibronectin levels. Biochem J (1986) 0.96
Identification of the cold-insoluble globulin of plasma in amniotic fluid. Am J Obstet Gynecol (1976) 0.96
Studies of fibronectin synthesized by cultured chick hepatocytes. Exp Cell Res (1985) 0.95
Cleavage of fibrinogen by human platelet calcium-activated protease. Thromb Res (1984) 0.95
Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin. Biochemistry (1988) 0.94
Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry (1981) 0.94
Application of electroimmunoassay to the study of plasma protein synthesis in cultured hepatocytes. Ann Clin Lab Sci (1980) 0.93
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest (1993) 0.93
Hormonal regulation of fibrinogen synthesis in cultured hepatocytes. Ann N Y Acad Sci (1983) 0.92
Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest (1987) 0.91
Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta (1987) 0.91
Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135. FEBS Lett (1987) 0.90
Comparison of the molecular forms of the Kex2/subtilisin-like serine proteases SPC2, SPC3, and furin in neuroendocrine secretory vesicles reveals differences in carboxyl-terminus truncation and membrane association. J Neurochem (1995) 0.89
Cold-insoluble globulin (CIg), a circulating cell surface protein. Thromb Haemost (1977) 0.88
Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates. J Biol Chem (1972) 0.88
Active site of alpha 1-antitrypsin: homologous site in antithrombin-III. Biochem Biophys Res Commun (1980) 0.88
Human plasma fibronectin structure probed by steady-state fluorescence polarization: evidence for a rigid oblate structure. Biochemistry (1990) 0.88
Proalbumin to albumin conversion by a proinsulin processing endopeptidase of insulin secretory granules. J Biol Chem (1989) 0.88
Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils. J Clin Invest (1988) 0.88
Solution and surface effects on plasma fibronectin structure. J Cell Biol (1983) 0.87
Chromatographic, ultracentrifugal, and related studies of fibrinogen "Baltimore". J Clin Invest (1969) 0.87
Expression, purification, and functional characterization of the serine protease inhibitor neuroserpin expressed in Drosophila S2 cells. Protein Expr Purif (2001) 0.87
Separation and analysis of the major forms of plasma fibronectin. Biochim Biophys Acta (1983) 0.87
Thyroid hormone stimulation of plasma protein synthesis in cultured hepatocytes. J Biol Chem (1981) 0.87
Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4. Biochemistry (1969) 0.86
Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and a patient with afibrinogenemia. J Clin Invest (1984) 0.86
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease. Ann N Y Acad Sci (2001) 0.86
Degradation of human adrenomedullin(1-52) by plasma membrane enzymes and identification of metabolites. Peptides (1997) 0.86
Studies of platelet fibrinogen from a subject with a congenital plasma fibrinogen abnormality (fibrinogen Paris I). Blood (1979) 0.86
Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol (2001) 0.86
Circulating proalbumin associated with a variant proteinase inhibitor. Biochim Biophys Acta (1984) 0.85
The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin. J Biol Chem (1990) 0.85
Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). Biochim Biophys Acta (1991) 0.85
Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. J Thromb Haemost (2008) 0.85
[Hemorrhagic diathesis with dominant heredity, caused by an abnormal fibrinogen (fibrinogen Baltimore)]. Schweiz Med Wochenschr (1966) 0.85
Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding. FEBS Lett (1990) 0.84
Primary structure of the amino terminal regions of chicken fibrin chains. Thromb Res (1977) 0.84
Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules. Blood (1988) 0.84
Fibrinogen Lincoln: a new truncated alpha chain variant with delayed clotting. Br J Haematol (1996) 0.84
Analysis of human fibrinogen by scanning transmission electron microscopy. Ann N Y Acad Sci (1983) 0.83
Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimers. Arch Biochem Biophys (1985) 0.83
alpha 1-Antitrypsin Christchurch, 363 Glu----Lys: mutation at the P'5 position does not affect inhibitory activity. Biochim Biophys Acta (1986) 0.83